Announcement of the Company holding investor presentation and Significant post press conference

Company will hold the Investor Conference
May 30, 2016
The company will publish the clinical study data of the innovation research of OBI-822/OBI-821 for metastatic breast cancer patients at the annual meeting of 2016 ASCO.
June 5, 2016

1.Date of occurrence of the event:2016/05/30
2.Company name: OBI Pharma, Inc.
3.Relationship to the Company (please enter ”head office” or ”affiliatecompany”): The Company head office
4.Reciprocal shareholding ratios: N/A
5.Name of mass media: N/A
6.Content reported: N/A
7.Cause of occurrence: The Company will present the Oral Abstract Sessions at ASCO in afternoon of 4th of June, American Time (Early morning of June 5, Taiwan Time) and will hold investor presentation and Significant post press conference at Taipei exchange center at 10:30 am, June 5, Taiwan time.
8.Countermeasures: None
9.Any other matters that need to be specified: Company operations and financial position all normal.